7 oktober 2026
Annual number of cancer diagnoses in the Netherlands projected to rise to almost 170,000 by 2045
The annual number of new cancer diagnoses in the Netherlands is projected to rise from more than 136,000 in 2025 to almost 170,000 in 2045. The number of people dying from cancer is also expected to increase, from more than 46,000 in 2024 to more than 57,000 in 2045. The main reason for these increases is the growing proportion of older people in the Netherlands. These are the findings of new projections of future cancer trends by the Netherlands Comprehensive Cancer Organisation (IKNL), presented at the symposium Looking Ahead: Cancer in the Future.
Read more
28 september 2026
Cancer registries remain the gold standard for understanding how cancer affects populations. The rigorous methods they use to collect and standardise data lead to high quality information, but can be time consuming and resource intensive. CancerWatch is improving Europe’s cancer intelligence by improving data quality and timeliness of data yet at manageable costs. To do so, a deep understanding of cancer registration in Europe is required.
Read more
CancerWatch builds stronger foundations for better cancer data across Europe
Cancer registries remain the gold standard for understanding how cancer affects populations. The rigorous methods they use to collect and standardise data lead to high quality information, but can be time consuming and resource intensive. CancerWatch is improving Europe’s cancer intelligence by improving data quality and timeliness of data yet at manageable costs. To do so, a deep understanding of cancer registration in Europe is required.
Read more
25 februari 2026
The number of people with cancer in the European Union has increased by around 30 percent since 2000. For 2024, approximately 2.7 million new diagnoses are expected. This development is putting pressure on healthcare systems, especially at a time when workforce capacity and budgets are limited. Against this backdrop, an international comparative report by the Organisation for Economic Co-operation and Development (OECD) and the European Commission states that delivering high-value cancer care is not a choice, but a necessity.
Read more
Dutch cancer care: strong foundation, clear opportunities for improvement
The number of people with cancer in the European Union has increased by around 30 percent since 2000. For 2024, approximately 2.7 million new diagnoses are expected. This development is putting pressure on healthcare systems, especially at a time when workforce capacity and budgets are limited. Against this backdrop, an international comparative report by the Organisation for Economic Co-operation and Development (OECD) and the European Commission states that delivering high-value cancer care is not a choice, but a necessity.
Read more
23 oktober 2025
The largest global analysis of care for women with breast, cervical and ovarian cancer shows substantial differences in stage at diagnosis, treatment and adherence to international guidelines. The study, published today in The Lancet, includes data from more than 275,000 women from cancer registries in 39 countries between 2015 and 2018. The Netherlands Comprehensive Cancer Organisation (IKNL) contributed data from the Netherlands Cancer Registry (NCR) and is co-author of the publication.
Read more
Worldwide differences in care for female-specific cancers
The largest global analysis of care for women with breast, cervical and ovarian cancer shows substantial differences in stage at diagnosis, treatment and adherence to international guidelines. The study, published today in The Lancet, includes data from more than 275,000 women from cancer registries in 39 countries between 2015 and 2018. The Netherlands Comprehensive Cancer Organisation (IKNL) contributed data from the Netherlands Cancer Registry (NCR) and is co-author of the publication.
Read more
23 september 2025
With a kick-off in Oslo, today marks the start of CancerWatch, a new EU Joint Action that will transform how Europe collects, harmonizes, and uses cancer data. Coordinated by the Norwegian Institute of Public Health and involving 92 partner organisations from 29 countries, CancerWatch will enhance the quality, comparability, and timeliness of data from population-based cancer registries (PBCRs) across Europe.
Read more
Europe launches CancerWatch
With a kick-off in Oslo, today marks the start of CancerWatch, a new EU Joint Action that will transform how Europe collects, harmonizes, and uses cancer data. Coordinated by the Norwegian Institute of Public Health and involving 92 partner organisations from 29 countries, CancerWatch will enhance the quality, comparability, and timeliness of data from population-based cancer registries (PBCRs) across Europe.
Read more
23 juni 2025
Healthcare is under pressure. People are living longer, but more often with chronic conditions and cancer. At the same time, workforce shortages are increasing, and workloads are rising. In this context, it is crucial to better utilize health data to ensure accessibility, quality, and affordability of care. Not just by making data available, but above all by making it 'fit for purpose'. IKNL plays a key role in this effort.
Read more
IKNL & EHDS: working together towards future-proof oncological care
Healthcare is under pressure. People are living longer, but more often with chronic conditions and cancer. At the same time, workforce shortages are increasing, and workloads are rising. In this context, it is crucial to better utilize health data to ensure accessibility, quality, and affordability of care. Not just by making data available, but above all by making it 'fit for purpose'. IKNL plays a key role in this effort.
Read more
8 mei 2025
OECD Cancer Profiles 2025: Where does the Netherlands stand in Europe?
How is the Netherlands performing in the fight against cancer? The European Cancer Country Profiles 2025, recently published by the OECD and the European Union, provide a detailed overview of how European countries are doing on cancer control — from incidence and mortality rates to prevention, screening, and healthcare spending.
Read more